Author

Carole A. Long

National Institute of Allergy and Infectious DiseasesORCID 0000-0002-3835-5443Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:rat· 1

Frequent Co-Authors

Kazutoyo MiuraiD· 2 shared Alexander D. DouglasiD· 1 shared Amelia M. LiasiD· 1 shared Amy R. NoeiD· 1 shared Andrey V. KajavaiD· 1 shared Ashley J. BirkettiD· 1 shared Barnabas G. WilliamsiD· 1 shared C. Richter KingiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Kazutoyo MiuraORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with sera from Plasmodium falciparum endemic areas of Africa

Saidou Balam, Kazutoyo Miura, Imen Ayadi, Drissa S Konate, Nathan C. Incandela, Valentina Agnolon, Merepen A. Guindo, Seidina A. S. Diakité, Sope Omowale Olugbile, Issa Nébié, Sonia M. Herrera, Carole A. Long, Andrey V. Kajava, Mahamadou Diakité, Giampietro Corradin, , Myriam Arévalo‐Herrera

This paper evaluates the cross-reactivity of a recombinant Plasmodium vivax protein with sera from Plasmodium falciparum-exposed individuals and demonstrates its transmission-blocking activity against P. falciparum.

PLoS ONE · Mar 18, 2025Peer-reviewedImmunology

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

Barnabas G. Williams, Lloyd D. W. King, David Pulido, Doris Quinkert, Amelia M. Lias, Sarah E. Silk, Robert J. Ragotte, H. Dele Davies, Jordan R. Barrett, Kirsty McHugh, Cassandra A. Rigby, Daniel G. W. Alanine, Lea Klingenberg Barfod, Michael William Shea, Li An Cowley, , Simon J. Draper

This paper develops a combination malaria vaccine targeting the RCR-complex by fusing epitopes from RIPR to CyRPA, improving in vitro growth inhibition compared to RH5.1 alone.

Nature Communications · Jun 7, 2024Peer-reviewedImmunology